May 31, 2019
Stand Up To Cancer – Funded Research To Be Presented At ASCO Annual Meeting May 31 – June 4 in Chicago
Researchers whose work has been supported by Stand Up To Cancer, including Uri Tabori, MD, Hospital for Sick Children, Toronto, and Nabil M. Ahmed, MD, Baylor College of Medicine, will discuss their work in advancing immunotherapy for pediatric brain tumors at the Annual Meeting 2019 of the American Society of Clinical Oncology May 31-June 4 at McCormick Place in Chicago.
Read MoreMay 2, 2019
“Innovation in Collaboration” among Research Teams Rewarded by Grants from Stand Up To Cancer
Stand Up To Cancer (SU2C) announced five new awards today drawing on the strengths of existing research activities to explore cross-cutting questions that have the potential of opening new paths to improved cancer treatment, according to the American Association for Cancer Research, SU2C’s Scientific Partner.
Read MoreApril 18, 2019
Stand Up To Cancer, Mastercard & Marvel Studios’ Avengers: Endgame Unite To Help Take Down One Of The Biggest Villains Of All: Cancer
Stand Up To Cancer (SU2C), Mastercard and Marvel Studios’ Avengers: Endgame announced today that they are teaming up to take down one of the biggest villains of all, cancer, with an impactful new Public Service Announcement scheduled to launch in April.
Read MoreApril 17, 2019
Key Protein A Possible New Target in the Treatment of Pancreatic Cancer Pancreatic Cancer Collective Supports Important Study Published in Nature
Research funded by the Pancreatic Cancer Collective, a partnership between Lustgarten Foundation and Stand Up To Cancer and guided by Dr. Tony Hunter at the Salk Institute was published today in Nature and has found that the interaction between pancreatic stellate cells (PSC’s) and pancreatic cancer cells could be “exploitable” due to the presence of a key protein and lead to the development of new targeted strategies for pancreatic cancer therapy.
Read MoreMarch 31, 2019
Stand Up To Cancer Supported Clinical Trials Seeking To Extend CAR T-cell Therapy to Solid Tumors, Reported at AACR Annual Meeting
Stand Up To Cancer (SU2C) is helping scientists make progress in one of the most important areas of cancer research today: expanding the use of autologous CAR T-cell immunotherapy beyond leukemia and other blood cancers to solid tumors such as osteosarcoma and mesothelioma. If ultimately successful, the research could pave the way for a dramatic expansion of a therapy that has revolutionized treatment of blood malignancies but thus far, has had little impact on the solid tumors that make up most cancer cases.
Read MoreMarch 30, 2019
The Pancreatic Cancer Collective Funds Two New Research Teams Using Artificial Intelligence to Identify High-Risk Pancreatic Cancer Populations
The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), today announced two, million-dollar grants for computational approaches to identifying high-risk pancreatic cancer populations.
Read MoreMarch 28, 2019
Stand Up To Cancer Hails Election of SU2C Team Leader as President-elect of American Association for Cancer Research
Stand Up To Cancer is hailing the election of active SU2C researcher and world-famous scientist, Antoni Ribas, MD, PhD, as the 2019-2020 president-elect of the American Association for Cancer Research, SU2C’s Scientific Partner.
Read MoreMarch 27, 2019
Stand Up To Cancer Funded Research to be Presented March 30 – April 3 at AACR Annual Meeting
Nobel Laureate James P. Allison, PhD, and other acclaimed researchers will be presenting their research funded by Stand Up To Cancer (SU2C) at the American Association for Cancer Research Annual (AACR) Meeting 2019 from March 29th to April 3rd, the Georgia World Congress Center (GWCC) in Atlanta.
Read MoreMarch 25, 2019
Stand Up To Cancer Grants First Peggy Prescott Award In Colorectal Cancer Research
Stand Up To Cancer (SU2C) today announced the recipient of its inaugural Stand Up To Cancer Peggy Prescott Early Career Scientist Award in Colorectal Cancer Research, which was funded by Dallas Cowboys QB and SU2C Ambassador Dak Prescott in memory of his mother who passed away from the disease in 2013. The fellowship provides $50,000 in research funding over a two-year term to a rising star in the colorectal cancer field.
Read MoreMarch 4, 2019
Pancreatic Cancer Collective Comments on Promising New Pancreatic Cancer
Lustgarten Foundation and Stand Up To Cancer, strategic partners in the Pancreatic Cancer Collective, offer comments on research published today in the journal Nature Medicine which describes a new therapeutic approach with promise for patients with pancreatic cancer.
Read More